Showing 1651-1660 of 10236 results for "".
Staying Compliant
https://practicaldermatology.com/topics/practice-management/staying-compliant/19081/Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions offer straight talk on compliance, suggesting that practice's turn to trusted experts who can focus on staying within the requirements of the law.Sunscreen Water Seems All Washed Up; Fake Cosmeceuticals Raise Concerns
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-sunscreen-water-seems-all-washed-up-fake-cosmeceuticals-raise-concerns/19119/In this edition of DermWireTV, from the publishers of Practical Dermatology® magazine we take a look at drinkable sunscreen and school bans on sunscreens, get an update on Vegas Cosmetic Surgery, and meet the new face of AMBI skincare. Plus, our DermFocus investigates the problem of counterfeit cosThe Dermatology Summit 2014
https://practicaldermatology.com/topics/practice-management/the-dermatology-summit-2014/19124/Highlights from The Dermatology Summit, 2014, held in San Francisco, sponsored by Advancing Innovation in Dermatology. See highlights from presenters and reactions from attendees. http://advancing-derm.org/meetings.phpSINON by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sinon-by-quantel-derma/19387/The ruby laser system with active Q-switch against natural pigmentations and tattoos. The Q-switched ruby laser system SINON has a wavelength of 694 nm. It applies ultra short pulses of only 20 ns for effective treatments even with low fluency. Thus, SINON is fast, reliable and gentle and able to rNew Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
https://practicaldermatology.com/series/dermwire-tv/new-clinical-guidelines-for-nonmelanoma-skin-cancer-treatment-arctics-biotherapeutics-seeks-new-fda-approval-for-zoryve-foam/26745/In this week’s DermwireTV, new clinical guidelines for nonmelanoma skin cancer treatment; Arcutis Biotherapeutics seeks new FDA approval for ZORYVE foam; Practical Dermatology joins the ReachMD network; and the CEO of SofWave Medical joins us to discuss the company’s Ultrasound technology.Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
https://practicaldermatology.com/series/dermwire-tv/study-examines-association-between-childhood-bmi-and-risk-of-developing-imsds/27004/In this week's DermwireTV, a new study examines the relationship between childhood BMI and skin diseases; phase 3 data sheds new light on dupilumab’s effect on inflammatory biomarkers in pediatric AD patients; and the president and CEO of Evolus discusses trends in the injectables market.DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-sdpa-president-amber-blair-pa-c-previews-her-new-column/27001/Amber Blair, PA-C, president of the Society of Dermatology Physician Associates, discusses important initiatives that she plans to cover in her new quarterly column in Practical Dermatology.PDT and Skin Cancer
https://practicaldermatology.com/series/pdt-in-practice/pdt-and-skin-cancer/20211/Dr. Joel L. Cohen, a board-certified dermatologist practicing in Denver, talks about how photodynamic therapy (PDT) has expanded treatment options for patients with skin cancers, and shares insights on how it can be integrated with care for patients with pre-cancerous abnormalities to prevent squamoAre you looking for a new social network? Look Nextdoor!
https://practicaldermatology.com/topics/practice-management/are-you-looking-for-a-new-social-network-look-nextdoor/20104/Are you are looking for ways to build your community reputation and expand your social media marketing horizons? If so, watch this short video from Ekwa Marketing (www.ekwa.com) to learn more about promoting your practice on Nextdoor.DermWireTV 09.12.19: Otezla to Amgen, A Juvéderm First, Skin Cancer Foundation News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-091219-otezla-to-amgen-a-juvederm-first-skin-cancer-foundation-news/19663/After traveling more than 10,000 miles across the US, the Skin Cancer Foundation’s “Destination: Healthy Skin” Program is wrapping up for the season. Plus, the Champions for Change Gala is coming October 17. Amgen has entered into an agreement with Celgene Corporation Company to acquire worldwide ri